KOD — Kodiak Sciences Income Statement
0.000.00%
Last trade - 00:00- $172.31m
- -$113.19m
- 19
- 43
- 69
- 39
Annual income statement for Kodiak Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 49.2 | 136 | 267 | 341 | 277 |
| Operating Profit | -49.2 | -136 | -267 | -341 | -277 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -47.4 | -133 | -267 | -334 | -260 |
| Net Income After Taxes | -47.4 | -133 | -267 | -334 | -260 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -47.4 | -133 | -267 | -334 | -260 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -47.4 | -133 | -267 | -334 | -260 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.25 | -2.91 | -5.16 | -6.39 | -4.97 |